Spots Global Cancer Trial Database for Polycystic Ovary Syndrome and Liraglutide
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Polycystic Ovary Syndrome and Liraglutide
Official Title: Short-term Liraglutide Treatment in Obese Women With Polycystic Ovary Syndrome
Study ID: NCT01899430
Study Description
Brief Summary: The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients treated with liraglutide than in those treated with metformin.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University Medical Center Ljubljana, Ljubljana, , Slovenia
Contact Details
Name: Andrej Janez, MD, PhD
Affiliation: University Medical Centre Ljubljana
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
